Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving its specialty preterm infant formulas.

O acordo foi firmado por três escritórios de advocacia que representam cerca de duas mil pessoas com ações contra a Abbott

Abbott agreed to a $670 million settlement to resolve claims over its preterm infant formulas, including dropping an appeal against a $495 million judgment from 2024.